Rantac Dom Tablets contain the active component Ranitidine and Domperidone. Ranitidine reduces stomach acid production as an H2 blocker. It can help relieve symptoms associated with conditions such as peptic ulcers, GERD, and Zollinger-Ellison syndrome. Zollinger-Ellison syndrome is a rare condition that causes excessive acid production in the stomach, leading to peptic ulcers. GERD is characterized by the backward flow of stomach acid into the esophagus, causing heartburn and acid reflux. By decreasing acid production, ranitidine can alleviate heartburn, indigestion, and stomach pain. As a dopamine receptor antagonist, Domperidone improves gastrointestinal motility and helps prevent nausea and vomiting. It is commonly used for gastroparesis, which involves delayed gastric emptying. Individuals with known hypersensitivity or allergy to Rantac Dom Tablets or any components should not use these medications. Certain individuals may have specific medical conditions or factors that increase the risk of adverse effects when combining Rantac Dom Tablets. These factors may include a history of cardiac arrhythmias, electrolyte imbalances, or gastrointestinal bleeding. These medications are excreted through the kidneys, and their use may require adjustment in individuals with kidney dysfunction. Elderly individuals are more susceptible to the side effects, such as confusion, dizziness, and cardiac effects. Close monitoring and dosage adjustments are necessary in this population to minimize the risk of adverse effects.